Young-Myeong Kim

Title: Young-Myeong Kim: Innovator in Angiogenesis Research

Introduction

Young-Myeong Kim is a prominent inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of medical research, particularly in the area of angiogenesis. His innovative work has the potential to impact therapeutic approaches for ischemic diseases.

Latest Patents

Young-Myeong Kim holds a patent for a method for stimulating angiogenesis using DKK2 and a composition comprising the same. This invention relates to the use of the DKK2 protein, which has demonstrated the ability to stimulate tube formation in human umbilical vein endothelial cells (HUVEC). The findings indicate that DKK2 promotes the sprouting of arterial circle tissues and enhances vascular development in mouse embryos. This research opens avenues for developing therapeutics or functional health foods aimed at treating and preventing ischemic diseases.

Career Highlights

Throughout his career, Young-Myeong Kim has been associated with Theragenetex Co., Ltd., where he has furthered his research and development efforts. His work has garnered attention for its innovative approach to addressing critical health issues.

Collaborations

Young-Myeong Kim has collaborated with notable colleagues, including Young-Guen Kwon and Jeong-Ki Min. These partnerships have contributed to the advancement of research in angiogenesis and related fields.

Conclusion

Young-Myeong Kim's contributions to angiogenesis research through his patented methods highlight his role as an influential inventor in the medical field. His work not only advances scientific understanding but also holds promise for future therapeutic applications.